The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran

Archives of Iranian Medicine

Volumn 16, Issue 1, 2013, Pages 17-19

  Kiani, Javad ^a   Moghimbeigi, Abbas ^b   Azizkhani, Homeyra ^a   Kosarifard, Soghra ^a  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Neuropathy; Prevalence; Risk factors

Indexed keywords

ADULT; AGE; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC FOOT; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; GENDER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPATHY DISABILITY SCORE; NEUROPATHY SYMPTOM SCORE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84871966167     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Vinik AI, Mitchell BD, Leichter SB, Wagner AL, Brian JT, Georges LP. Epidemiology of the complications of Diabetes. In: Leslie RDG, Robbins DC (eds) Diabetes: Clinical science in Practice. Cambridge University Press, Cambridge. 1195; 221-287.
2. Boulton Ajm, Malik Ra, Arezz Jc, Sosenko JM. Diabetic somatic neuropatheis. Diabetes Care. 2004; 27: 1458-1486.
3. Garcia JM, Velasco PP, Cabrerizo L, Pe ́rez M, Go ́mez VL. Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years' disease duration. Endocrinol Nutr. 2010; 57(9): 414-420.
4. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993; 36: 1-5.
5. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology. 1993; 43: 817-824.
6. Cabezas-Cerrato J; for the Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS): The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia. 1998; 41: 1263-1269.
7. Tabatabaei O, Mohajeri MR, Madani SP, Heshmat R, Larijani B. The prevalence of diabetic peripheral neuropathy and related factors. Iranian J Publ Health. 2011; 40(3): 55-62.
8. Rahimdel A, Afkhami M, Souzani A, Modaresi M, Mashahiri MR. Prevalence of sensory neuropathy in type 2 diabetic patients in Iranian population (Yazd province). Iranian Journal of Diabetes and Obesity. 2009; 1(1): 30-35.
9. Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, Amini M. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Int J Diabetes & Metabolism. 2006; 14: 126-133.
10. American Diabetes Association. Standards of medical care in diabetes- 2010. Diabetes Care. 2010; 29: 11-61.
11. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995; 45: 1115-1121.
12. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993; 36: 1-5.
13. Barbosa AP, Medina JL, Ramos EP, Barros HP, and the DPN in Porto study group. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population. Diabetes Metab. 2001; 27: 496-502.
14. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian first nation community. Diabetes Care. 2008; 31: 1837-1841.
15. Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract. 2004; 17: 309-318.